Universal Vision Biotechnology Co., Ltd. (3218.TWO)
TWD 202.5
(-1.94%)
TWD 202.5
(-1.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.55 Billion | 1.26 Billion | 911.77 Million | 827.08 Million | 419.18 Million |
| Net Income | 1.31 Billion | 1.09 Billion | 763.1 Million | 602.13 Million | 238 Million |
| Depreciation & Amortization | 446.14 Million | 372.25 Million | 319.52 Million | 263.96 Million | 242.88 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -9.04 Million | -47.54 Million | -42.13 Million | 38.17 Million | -31.08 Million |
| Other non-cash items | -5.04 Million | 2.91 Million | 7.57 Million | 3.59 Million | -30.62 Million |
| Investing Cash Flow | -476.95 Million | -564.65 Million | -379.8 Million | -419.2 Million | -223.38 Million |
| Investments in PPE | -474.28 Million | -492.83 Million | -328.7 Million | -298.5 Million | -235.18 Million |
| Acquisitions | -62.02 Million | - | - | -8.15 Million | - |
| Investment purchases | -1.74 Million | -70.81 Million | -44.05 Million | -122.78 Million | - |
| Sales/Maturities of investments | - | - | - | - | 30.1 Million |
| Other Investing Activities | -1.07 Million | -1.13 Million | -7.11 Million | -1.66 Million | 11.8 Million |
| Financing Cash Flow | -710.65 Million | -539.83 Million | -612.33 Million | -164.61 Million | -282.73 Million |
| Debt repayment | -354 Thousand | -9.22 Million | -157.12 Million | -100 Million | -117.57 Million |
| Dividends payments | -479.57 Million | -380.61 Million | -319.71 Million | -152.24 Million | -95.15 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -62.09 Million | 5 Million | 30 Thousand | 5 Million | -70.01 Million |
| Accounts receivables | -6.76 Million | -54.54 Million | -158.12 Million | -34.99 Million | -23.74 Million |
| Accounts payables | 57.75 Million | - | - | - | - |
| Inventory | -89.84 Million | -111.63 Million | -47.31 Million | -1.26 Million | -2.15 Million |
| Other working capital | 29.81 Million | 74.57 Million | 75.73 Million | 27.98 Million | -5.18 Million |
| Cash at beginning of period | 703.01 Million | 534.19 Million | 616 Million | 372.13 Million | 466.34 Million |
| Cash at end of period | 1.06 Billion | 703.01 Million | 534.19 Million | 616 Million | 372.13 Million |
| Capital Expenditure | -474.28 Million | -492.83 Million | -328.7 Million | -298.5 Million | -235.18 Million |
| Effect of forex changes on cash | -6.46 Million | 5.14 Million | -1.44 Million | 605 Thousand | -7.27 Million |
| Net cash flow / Change in cash | 359.52 Million | 168.82 Million | -81.81 Million | 243.86 Million | -94.21 Million |
| Free Cash Flow | 1.07 Billion | 775.33 Million | 583.07 Million | 528.57 Million | 183.99 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 278.14 Million | 303.88 Million | 318.55 Million | 1.31 Billion | 334.59 Million | 324.34 Million |
| Depreciation & Amortization | 125.94 Million | 119.66 Million | 117.85 Million | 446.14 Million | 113.8 Million | 109.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -29.82 Million | 27.39 Million | 3.82 Million | -9.04 Million | -12.11 Million | -18.73 Million |
| Other non-cash items | -91.34 Million | 27.5 Million | -4.16 Million | -5.04 Million | 77 Thousand | -461 Thousand |
| Investing Cash Flow | 106.12 Million | -273.93 Million | 44.66 Million | -476.95 Million | -103.7 Million | -292.55 Million |
| Investments in PPE | -113.59 Million | -68.9 Million | -94.9 Million | -474.28 Million | -145.14 Million | -146.59 Million |
| Acquisitions | - | -66.92 Million | - | - | - | - |
| Investment purchases | 173.37 Million | -204.55 Million | 139.94 Million | -1.74 Million | 42.51 Million | -145.77 Million |
| Sales/Maturities of investments | 45.64 Million | - | - | - | - | - |
| Other Investing Activities | 219.71 Million | -205.03 Million | -382 Thousand | -1.07 Million | -1.08 Million | -216 Thousand |
| Financing Cash Flow | -664.94 Million | -78.43 Million | -103.69 Million | -710.65 Million | -524.1 Million | -44.36 Million |
| Debt repayment | -45.39 Million | -44.04 Million | -6.53 Million | -354 Thousand | -2.29 Million | -2.27 Million |
| Dividends payments | -593.07 Million | - | - | -479.57 Million | -479.57 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -26.47 Million | -34.39 Million | -67.11 Million | -62.09 Million | -16 Thousand | -10 Thousand |
| Accounts receivables | -28.77 Million | 47.6 Million | -27.67 Million | -6.76 Million | -34.88 Million | 16.44 Million |
| Accounts payables | -15.14 Million | -48.81 Million | - | - | - | - |
| Inventory | 4.94 Million | 4.27 Million | -23.35 Million | -89.84 Million | -13.63 Million | -17.54 Million |
| Other working capital | -5.99 Million | -24.48 Million | 16.41 Million | 29.81 Million | 40.77 Million | 7.25 Million |
| Cash at beginning of period | 1.2 Billion | 1.06 Billion | 688.23 Million | 703.01 Million | 965.59 Million | 1 Billion |
| Cash at end of period | 931.21 Million | 1.2 Billion | 1.06 Billion | 1.06 Billion | 688.23 Million | 965.59 Million |
| Capital Expenditure | -113.59 Million | -68.9 Million | -94.9 Million | -474.28 Million | -145.14 Million | -146.59 Million |
| Effect of forex changes on cash | 3.09 Million | 15.39 Million | -13.88 Million | -6.46 Million | 15.73 Million | -10.04 Million |
| Net cash flow / Change in cash | -272.8 Million | 141.47 Million | 374.3 Million | 359.52 Million | -277.35 Million | -38.06 Million |
| Free Cash Flow | 169.32 Million | 409.54 Million | 352.31 Million | 1.07 Billion | 189.58 Million | 162.3 Million |
GBLI
PPIH
8077
WVVI
0HVB
IPGP